UnitedHealth Group (NYSE:UNH) PT Raised to $298.00

UnitedHealth Group (NYSE:UNH) had its price target increased by investment analysts at Morgan Stanley from $285.00 to $298.00 in a research note issued on Friday, BenzingaRatingsTable reports. The brokerage presently has an “overweight” rating on the healthcare conglomerate’s stock. Morgan Stanley’s target price would suggest a potential upside of 12.07% from the company’s previous close.

Several other brokerages have also weighed in on UNH. SunTrust Banks dropped their price objective on shares of UnitedHealth Group to $300.00 and set a “buy” rating on the stock in a research report on Wednesday, April 17th. They noted that the move was a valuation call. ValuEngine lowered shares of Acceleron Pharma from a “strong-buy” rating to a “buy” rating in a research report on Thursday, April 18th. Zacks Investment Research lowered shares of HENGAN INTL GRP/ADR from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, May 21st. UBS Group set a $36.00 price objective on shares of Halliburton and gave the company a “buy” rating in a research report on Tuesday, April 23rd. Finally, Raymond James set a $8.00 price objective on shares of Superior Energy Services and gave the company a “buy” rating in a research report on Wednesday, April 17th. One investment analyst has rated the stock with a sell rating, two have given a hold rating, eighteen have assigned a buy rating and one has assigned a strong buy rating to the company. The company currently has an average rating of “Buy” and a consensus price target of $291.53.

Shares of UNH stock opened at $265.90 on Friday. The firm has a market capitalization of $248.19 billion, a PE ratio of 20.64, a P/E/G ratio of 1.40 and a beta of 0.61. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.63. The company has a fifty day moving average price of $246.51. UnitedHealth Group has a one year low of $208.07 and a one year high of $287.94.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $3.73 EPS for the quarter, beating analysts’ consensus estimates of $3.60 by $0.13. The firm had revenue of $60.30 billion during the quarter, compared to analysts’ expectations of $59.72 billion. UnitedHealth Group had a net margin of 5.45% and a return on equity of 25.07%. The company’s revenue for the quarter was up 9.2% compared to the same quarter last year. During the same quarter last year, the company posted $3.04 earnings per share. On average, research analysts expect that UnitedHealth Group will post 14.7 EPS for the current fiscal year.

In related news, Director William C. Ballard, Jr. sold 5,000 shares of the firm’s stock in a transaction dated Monday, May 6th. The shares were sold at an average price of $239.02, for a total transaction of $1,195,100.00. Following the transaction, the director now directly owns 77,993 shares of the company’s stock, valued at $18,641,886.86. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Richard T. Burke sold 10,000 shares of the firm’s stock in a transaction dated Tuesday, June 11th. The stock was sold at an average price of $248.00, for a total transaction of $2,480,000.00. Following the transaction, the director now directly owns 187,663 shares in the company, valued at $46,540,424. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 35,000 shares of company stock worth $8,392,500. 0.87% of the stock is owned by insiders.

Large investors have recently added to or reduced their stakes in the stock. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA grew its stake in UnitedHealth Group by 3.9% during the first quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA now owns 1,132 shares of the healthcare conglomerate’s stock worth $280,000 after buying an additional 43 shares in the last quarter. CRA Financial Services LLC grew its stake in UnitedHealth Group by 2.7% during the first quarter. CRA Financial Services LLC now owns 1,792 shares of the healthcare conglomerate’s stock worth $444,000 after buying an additional 47 shares in the last quarter. Pratt Collard Advisory Partners LLC grew its stake in UnitedHealth Group by 5.7% during the first quarter. Pratt Collard Advisory Partners LLC now owns 877 shares of the healthcare conglomerate’s stock worth $217,000 after buying an additional 47 shares in the last quarter. Squar Milner Financial Services LLC grew its stake in UnitedHealth Group by 2.3% during the first quarter. Squar Milner Financial Services LLC now owns 2,073 shares of the healthcare conglomerate’s stock worth $512,000 after buying an additional 47 shares in the last quarter. Finally, YorkBridge Wealth Partners LLC grew its stake in UnitedHealth Group by 0.6% during the fourth quarter. YorkBridge Wealth Partners LLC now owns 8,407 shares of the healthcare conglomerate’s stock worth $2,094,000 after buying an additional 48 shares in the last quarter. 85.62% of the stock is currently owned by institutional investors and hedge funds.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Read More: What is meant by a buy rating?

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.